Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- PMID: 21199103
- DOI: 10.1111/j.1529-8027.2010.00292.x
Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) remains the principal dose-limiting toxicity of many agents. This systematic review evaluates available CIPN measures and provides rationale for selection of measures in this field. Searches of Medline (1966-2010), CINAHL (1966-2010), Embase (1966-2010), and Cochrane (1988-2010) databases were performed. To be selected, studies had to include (1) subjects receiving peripheral neurotoxic chemotherapy for cancer and (2) a primary purpose of psychometric evaluation of CIPN measures. A modified Quality of Diagnostic Accuracy Studies (QUADAS) tool coded psychometric study quality, with 0-7 score overall possible (higher score indicating better quality). A total of 15 studies qualified for evaluation. Overall studies were of moderate quality, with 10 of 15 receiving a 4-5 QUADAS score. Averaged quality scores for two repeatedly studied measures, Total Neuropathy Score (TNS) versions and Functional Assessment of Cancer-Gynecologic Oncology Group, neurotoxicity (FACT/GOG-Ntx), were 5.4 and 4.5, respectively. Two measures emerged as potentially useful for clinical trials and patient care. The FACT/GOG-Ntx is a subjective measure of CIPN-related quality of life (QoL). TNS clinical versions incorporate both subjective measures and objective examinations of nerve function. However, to improve QUADAS scoring, additional research is needed focusing on other psychometric aspects such as responsiveness of CIPN outcome measures.
© 2010 Peripheral Nerve Society.
Similar articles
-
Chemotherapy-Induced Peripheral Neuropathy Assessment Tools: A Systematic Review.Oncol Nurs Forum. 2017 May 1;44(3):E111-E123. doi: 10.1188/17.ONF.E111-E123. Oncol Nurs Forum. 2017. PMID: 28635977
-
Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use.Qual Life Res. 2022 Nov;31(11):3091-3107. doi: 10.1007/s11136-022-03154-7. Epub 2022 May 21. Qual Life Res. 2022. PMID: 35596913 Free PMC article.
-
Assessment measures for chemotherapy-induced peripheral neuropathy among pediatric oncology patients: an updated systematic review.Support Care Cancer. 2025 May 29;33(6):514. doi: 10.1007/s00520-025-09515-5. Support Care Cancer. 2025. PMID: 40442349 Free PMC article. Review.
-
Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With Cancer.J Med Internet Res. 2025 Feb 5;27:e65615. doi: 10.2196/65615. J Med Internet Res. 2025. PMID: 39908091 Free PMC article.
-
Systemic treatments for metastatic cutaneous melanoma.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article.
Cited by
-
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.J Peripher Nerv Syst. 2014 Jun;19(2):127-35. doi: 10.1111/jns5.12064. J Peripher Nerv Syst. 2014. PMID: 24814100 Free PMC article.
-
Vincristine-induced peripheral neuropathy in pediatric cancer patients.Am J Cancer Res. 2016 Nov 1;6(11):2416-2430. eCollection 2016. Am J Cancer Res. 2016. PMID: 27904761 Free PMC article. Review.
-
Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.Support Care Cancer. 2017 Nov;25(11):3485-3493. doi: 10.1007/s00520-017-3772-y. Epub 2017 Jun 7. Support Care Cancer. 2017. PMID: 28589310
-
Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.Front Pharmacol. 2021 Apr 22;12:637593. doi: 10.3389/fphar.2021.637593. eCollection 2021. Front Pharmacol. 2021. PMID: 33967771 Free PMC article.
-
Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.Support Care Cancer. 2017 Nov;25(11):3437-3446. doi: 10.1007/s00520-017-3764-y. Epub 2017 Jun 2. Support Care Cancer. 2017. PMID: 28577231
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical